Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation
Study Details
Study Description
Brief Summary
The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unintended pregnancy soon after childbirth by increasing access to immediate postpartum LARC for women who desire it.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Based on previous work, the investigators have generated a toolkit to guide the integration of immediate postpartum LARC services into widespread clinical practice. In the proposed work, this toolkit will be used to initiate immediate postpartum LARC services in a single site with low baseline immediate postpartum LARC uptake (Michigan Medicine). The investigators will conduct a feasibility study using mixed methods to assess acceptability and appropriateness of toolkit items; patient experience of care; immediate postpartum LARC utilization rate; and prenatal contraceptive counseling rate.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Pre-Implementation Patients Enrolled patients will take online surveys following a prenatal or a postpartum visit. |
|
| Post-Implementation Patients All enrolled patients will take online surveys following a prenatal or a postpartum visit. A subset will be interviewed after the postpartum survey. |
Other: Implementation Toolkit
Post-implementation patients and providers will be assessed after the implementation toolkit has been used to improve service delivery at the study site.
|
| Post-Implementation Providers All enrolled providers will take online surveys at 6-12 months after program implementation, and a subset will be interviewed. |
Other: Implementation Toolkit
Post-implementation patients and providers will be assessed after the implementation toolkit has been used to improve service delivery at the study site.
|
Outcome Measures
Primary Outcome Measures
- Patient experience of care [Surveys will be collected from pregnant or postpartum women, during the 6-12 months after implementation of a new protocol for peripartum contraceptive care]
Patient online surveys about their experience of care during prenatal visits, hospital stay, or postpartum office visit
- Acceptability of care process - patients [Surveys will be collected from pregnant or postpartum women, during the 6-12 months after implementation of a new protocol for peripartum contraceptive care]
Online survey assessing experience of care, acceptability and appropriateness of implementation tools
- Appropriateness of care process - patients [Surveys will be collected from pregnant or postpartum women, during the 6-12 months after implementation of a new protocol for peripartum contraceptive care]
Online survey assessing experience of care, acceptability and appropriateness of implementation tools
- Acceptability of implementation process - study site maternity care providers [Surveys will be collected during the 6-12 months after implementation of a new protocol for peripartum contraceptive care]
Online survey assessing overall experience of care delivery, acceptability and appropriateness of implementation tools
- Appropriateness of implementation process - study site maternity care providers [Surveys will be collected during the 6-12 months after implementation of a new protocol for peripartum contraceptive care]
Online survey assessing overall experience of care delivery, acceptability and appropriateness of implementation tools
Secondary Outcome Measures
- Acceptability of implementation toolkit items - patients [Interviews will take place after the survey is completed, during the 6-18 months after implementation of a new protocol for peripartum contraceptive care]
30-minute follow-up in-person interview of subgroup of patients who completed surveys
- Appropriateness of implementation toolkit items - patients [Interviews will take place after the survey is completed, during the 6-18 months after implementation of a new protocol for peripartum contraceptive care]
30-minute follow-up in-person interview of subgroup of patients who completed surveys
- Acceptability of implementation toolkit items - providers [Interviews will take place after the survey is completed, during the 6-18 months after implementation of a new protocol for peripartum contraceptive care]
30-minute follow-up in-person interview of subgroup of providers who completed survey
- Appropriateness of implementation toolkit items - providers [Interviews will take place after the survey is completed, during the 6-18 months after implementation of a new protocol for peripartum contraceptive care]
30-minute follow-up in-person interview of subgroup of providers who completed survey
- Perinatal contraceptive counseling rate [Measured monthly, up to 24 months after toolkit implementation]
Proportion of delivered patients with documentation of prenatal counseling about postpartum contraception
- Immediate postpartum LARC provision rate [Measured monthly, up to 24 months after toolkit implementation]
Proportion of delivered patients with documentation of preference for immediate postpartum LARC who receive a LARC device
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Female (patients)
-
Pregnant (patients)
-
Receiving obstetrical care at Michigan Medicine (patients)
-
L&D provider at Michigan Medicine (providers)
Exclusion Criteria:
-
non-English speaking
-
unable to provide informed consent
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Michigan Medicine | Ann Arbor | Michigan | United States | 48109 |
Sponsors and Collaborators
- University of Michigan
- Agency for Healthcare Research and Quality (AHRQ)
Investigators
- Principal Investigator: Michelle H. Moniz, MD, MSc, University of Michigan
- Principal Investigator: Vanessa K. Dalton, MD, MPH, University of Michigan
- Principal Investigator: Michelle Heisler, MD, MPH, University of Michigan
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HUM00126810